EUVIMEDEUVIMED entdecken
Crossref

Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance

Juliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, Flavia Bonini, Luana Guimaraes de Sousa, Mario L Marques-Piubelli, Anurag Purushothaman, Mutsumi Mitani, Hui Dai, Shiaw-Yih Lin, Michael T Spiotto, Ehab Y Hanna und 3 weitere

Modern Pathology · 2024-01 · 37 (1) · 100371

DOI: 10.1016/j.modpat.2023.100371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-01. Verfasst von Juliana Mota Siqueira und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Stomatology, …. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Carcinoma, Acinar Cell, Salivary Gland Neoplasms, Carcinoma, Mucoepidermoid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Department of Defense, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B7-H4 (VTCN1), a member of the B7 family, is overexpressed in several types of cancer. Here we investigated the pattern of expression of B7-H4 in salivary gland carcinomas (SGC) and assessed its potential as a prognostic marker and therapeutic target. Immunohistochemistry (IHC) analyses were performed in a cohort of 340 patient tumors, composed of 124 adenoid cystic carcinomas (ACC), 107 salivary duct carcinomas (SDC), 64 acinic cell carcinomas, 36 mucoepidermoid carcinomas (MEC), 9 secretory carcinomas (SC), as well as 20 normal salivary glands (controls). B7-H4 expression was scored and categorized into negative ( 70% with weak intensity), or high (>70% moderate or strong diffuse intensity). The associations between B7-H4 expression and clinicopathologic characteristics, as well as overall survival, were assessed. Among all tumors, B7-H4 expression was more prevalent in ACC (94%) compared with those of SC (67%), MEC (44%), SDC (32%), and acinic cell carcinomas (0%). Normal salivary gland tissue did not express B7-H4. High expression of B7-H4 was found exclusively in ACC (27%), SDC (11%), and MEC (8%). In SDC, B7-H4 expression was associated with female gender (P = .002) and lack of androgen receptor expression (P = .012). In ACC, B7-H4 expression was significantly associated with solid histology (P < .0001) and minor salivary gland primary (P = .02). High B7-H4 expression was associated with a poorer prognosis in ACC, regardless of clinical stage and histologic subtype. B7-H4 expression was not prognostic in the non-ACC SGC evaluated. Our comparative study revealed distinct patterns of B7-H4 expression according to SGC histology, which has potential therapeutic implications. B7-H4 expression was particularly high in solid ACC and was an independent prognostic marker in this disease but not in the other SGC assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticCarcinoma, Acinar CellSalivary Gland NeoplasmsCarcinoma, MucoepidermoidCarcinomaHumansFemalePrognosisSalivary GlandsBiomarkers, TumorBreast Neoplasms

Stichwörter der Autor:innen

B7-H4/VTCN1acinic cell carcinomaadenoid cystic carcinomaimmunohistochemistrymucoepidermoid carcinomasalivary duct carcinomasalivary gland carcinomas

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Stomatology, Discipline of Oral and Maxillofacial Pathology, School of Dentistry, U…
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Förderung

  • Department of Defense
  • NCI NIH HHS

Zitieren

APA

Siqueira, J. M., Mitani, Y., Hoff, C. O., Bonini, F., Guimaraes de Sousa, L., Marques-Piubelli, M. L., Purushothaman, A., Mitani, M., Dai, H., Lin, S. Y., Spiotto, M. T., Hanna, E. Y., McGrail, D. J., El-Naggar, A. K., & Ferrarotto, R. (2024). Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance. Modern Pathology, 37(1), 100371. https://doi.org/10.1016/j.modpat.2023.100371

Vancouver

Siqueira JM, Mitani Y, Hoff CO, Bonini F, Guimaraes de Sousa L, Marques-Piubelli ML, et al. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance. Modern Pathology. 2024;37(1):100371. doi:10.1016/j.modpat.2023.100371

BibTeX
@article{Siqueira2024,
  author = {Siqueira, Juliana Mota and Mitani, Yoshitsugu and Hoff, Camilla Oliveira and Bonini, Flavia and Guimaraes de Sousa, Luana and Marques-Piubelli, Mario L and Purushothaman, Anurag and Mitani, Mutsumi and Dai, Hui and Lin, Shiaw-Yih and Spiotto, Michael T and Hanna, Ehab Y and McGrail, Daniel J and El-Naggar, Adel K and Ferrarotto, Renata},
  title = {Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {1},
  pages = {100371},
  doi = {10.1016/j.modpat.2023.100371}
}
Kostenlos starten →